Catinazzo Thomas 4

What Happened
Thomas Catinazzo, CFO of Relay Therapeutics, disposed of a total 15,515 shares in two sales to satisfy tax-withholding obligations tied to RSU vesting. On 2026-01-27 he sold 13,820 shares at $7.62 each for $105,308; on 2026-01-28 he sold 1,695 shares at $8.45 each for $14,323. These transactions were sales (disposals), not purchases.

Key Details

• Transaction dates & prices: 2026-01-27 — 13,820 shares @ $7.62; 2026-01-28 — 1,695 shares @ $8.45.
• Total proceeds: $119,631.
• Footnotes: F1/F3 — Sales were made to cover income tax withholding upon vesting of RSUs (42,394 RSUs vested on Jan 26 and 5,724 RSUs vested on Jan 27). The reporting person had no discretion; sales were transacted per the issuer’s RSU vesting policies.
• Ownership notes in filing: F2 — includes 18,799 shares underlying RSUs; F4 — includes 13,075 shares underlying RSUs. The filing does not state an explicit aggregate post-sale share total.
• Filing timeliness: Form 4 filed 2026-01-29 — appears to be timely.

Context
These were routine tax-withholding dispositions following RSU vesting rather than discretionary sales or purchases. Such cashless or sell-to-cover transactions are common and generally reflect withholding mechanics, not necessarily a change in insider sentiment.